Veeva Systems Inc. Class A (VEEV) Covered Calls

Veeva Systems Inc. is the leading provider of industry cloud solutions for the global life sciences industry. The company offers a comprehensive suite of cloud-based software, data, and analytics tailored to the unique regulatory and operational needs of pharmaceutical, biotech, and medical device companies. Its flagship Vault platform integrates clinical, regulatory, quality, and commercial functions, enabling organizations to bring products to market faster and maintain compliance.

You can sell covered calls on Veeva Systems Inc. Class A to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for VEEV (prices last updated Tue 4:16 PM ET):

Want to make money with covered calls?  Sign Up For A Free Trial

Veeva Systems operates as a pure-play Software-as-a-Service (SaaS) leader dedicated to the life sciences sector. Its business model is built around the "Industry Cloud," which provides a unified platform to manage the entire product lifecycle—from initial R&D and clinical trials to commercialization and post-market safety. The company’s core architecture, Veeva Vault, allows customers to eliminate fragmented legacy systems by providing a single source of truth for both content and data, ensuring rigorous adherence to FDA and international regulatory standards.

The company generates the vast majority of its revenue through high-margin, recurring subscriptions. Its ecosystem is divided into the Development Cloud, which supports clinical operations and regulatory management, and the Commercial Cloud, which includes its proprietary Vault CRM and data analytics tools. By transitioning customers from generalist platforms to industry-specific software, Veeva creates deep operational lock-in and maintains high net retention rates among the world’s largest biopharmaceutical enterprises.

Competition

The competitive landscape for life sciences software is intensifying as the industry moves toward "agentic" AI and cloud-native architectures. Veeva competes primarily with diversified enterprise software giants and specialized clinical data providers. The shift toward integrated, end-to-end platforms has led to significant rivalry in the CRM and clinical trial management segments, with competitors often leveraging established relationships with large health systems or broad digital ecosystems to challenge Veeva’s market share.

Success in this specialized market depends on maintaining "validated" software status and continuous innovation in AI-driven insights. Key publicly traded, optionable competitors include Salesforce, Oracle, and IQVIA Holdings.

Strategic Outlook and Innovation

Veeva is focused on its "agentic transformation," integrating industry-specific AI agents directly into its core applications to automate complex workflows in R&D and commercial operations. A primary strategic priority is the successful migration of its customer base to the new Vault CRM, its proprietary alternative to legacy third-party platforms. The firm also aims to expand its reach within the "Development Cloud" by modernizing pharmacovigilance and laboratory information management systems (LIMS).

Innovation is centered on the use of specialized datasets to train AI models that assist with clinical trial design, regulatory submissions, and personalized medical affairs engagement. By maintaining its status as a Public Benefit Corporation, the company aligns its long-term growth with the interests of the broader life sciences community. The focus remains on achieving its long-term revenue targets through product excellence and the continued digitization of the global laboratory and clinical environment.

Want more examples? VECO Covered Calls | VEGI Covered Calls